Home/Centessa Pharmaceuticals/Stephen Kanes, MD, PhD
SK

Stephen Kanes, MD, PhD

Head of R&D and Chief Medical Officer

Centessa Pharmaceuticals

Centessa Pharmaceuticals Pipeline

DrugIndicationPhase
ORX750Narcolepsy Type 1 (NT1)Phase 2
ORX142Neurological & Neurodegenerative DisordersPre-clinical
ORX489Neuropsychiatric DisordersPre-clinical
LockBody Platform AssetsOncologyPre-clinical